Search - Université de Lyon Access content directly

Filter your results

9 Results
authFullName_s : Anne-Claire Toffart
Image document

Evaluation of RECIST in chemotherapy-treated lung cancer: the Pharmacogenoscan Study

Anne-Claire Toffart , Denis Moro-Sibilot , Sébastien Couraud , Patrick Merle , Maurice Pérol , et al.
BMC Cancer, 2014, 14, pp.1-7. ⟨10.1186/1471-2407-14-989⟩
Journal articles hal-02633854v1
Image document

Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study

Charles-Hugo Marquette , Jacques Boutros , Jonathan Benzaquen , Marion Ferreira , Jean Pastre , et al.
The Lancet Respiratory Medicine, 2020, 8 (7), pp.709-716. ⟨10.1016/S2213-2600(20)30081-3⟩
Journal articles hal-02897076v1

Implementing ctDNA Analysis in the Clinic: Challenges and Opportunities in Non-Small Cell Lung Cancer

Elisa Gobbini , Aurélie Swalduz , Matteo Giaj Levra , Sandra Ortiz-Cuaran , Anne-Claire Toffart , et al.
Cancers, 2020, 12 (11), pp.3112. ⟨10.3390/cancers12113112⟩
Journal articles hal-03851821v1
Image document

Literature meta-analysis about the efficacy of re-challenge with PD-1 and PD-L1 inhibitors in cancer patients

Elisa Gobbini , Julie Charles , Anne-Claire Toffart , Marie-Thérèse Leccia , Denis Moro-Sibilot , et al.
Bulletin du Cancer, 2020, 107, pp.1098 - 1107. ⟨10.1016/j.bulcan.2020.07.009⟩
Journal articles hal-03493443v1

Patients with advanced lung cancer harboring oncogenic mutations should be admitted to intensive care units

Anne-Claire Toffart , Xavier Dhalluin , Nicolas Girard , Christos Chouaid , Clarisse Audigier-Valette , et al.
Intensive Care Medicine, 2015, 41 (1), pp.164-165. ⟨10.1007/s00134-014-3535-x⟩
Journal articles hal-02637257v1
Image document

Thoracic NUT carcinoma: Common pathological features despite diversity of clinical presentations

Amal Fekkar , Camille Emprou , Christine Lefebvre , Gilbert Ferretti , Olivier Stephanov , et al.
Journal articles hal-03364416v1
Image document

Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018

Olivier Bylicki , Pascale Tomasini , Gervais Radj , Florian Guisier , Isabelle Monnet , et al.
European Journal of Cancer, 2023, 183, pp.38-48. ⟨10.1016/j.ejca.2023.01.014⟩
Journal articles hal-04016683v1

Aide à la décision de transfert ou non transfert en réanimation d’un patient atteint de cancer

Gisèle Chvetzoff , François Blot , Alexis Burnod , Chantal Bauchetet , Marie Beaumont , et al.
2016
Other publications hal-01985546v1
Image document

Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids

Nicolas Alcala , Noémie Leblay , Aurélie Gabriel , Lise Mangiante , Davis Hervás , et al.
Nature Communications, 2019, 10 (1), pp.1-21. ⟨10.1038/s41467-019-11276-9⟩
Journal articles hal-02339242v1